Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Nov-23 2:46 PM View:  | Richardson Linda M EVP & Chief Commercial Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 26,585 | $19.00 | $505,115.00 | (61%) 43.29K to 16.71K | |
| 13-Nov-23 2:47 PM View: | Fundaro Paolo Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (18%) 43.91K to 35.79K | |
| 13-Nov-23 2:41 PM View: | Bradbury Daniel Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (21%) 39.47K to 31.36K | |
| 13-Nov-23 2:46 PM View: | Richardson Linda M EVP & Chief Commercial Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 16,706 | $19.00 | $317,414.00 | (100%) 16.71K to 0 | |
| 13-Nov-23 2:40 PM View: | Durso Jerome Benedict CEO Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 51,815 | $19.00 | $984,485.00 | (100%) 51.81K to 0 | |
| 13-Nov-23 2:46 PM View: | Luca Benatti Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 25,487 | $19.00 | $484,253.00 | (100%) 25.49K to 0 | |
| 13-Nov-23 2:45 PM View: | Sblendorio Glenn Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 23,447 | $19.00 | $445,493.00 | (100%) 23.45K to 0 | |
| 13-Nov-23 2:42 PM View: | Ford David A Chief Human Resources Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 21,400 | $19.00 | $406,600.00 | (59%) 36.44K to 15.04K | |
| 13-Nov-23 2:43 PM View: | Gottesdiener Keith Michael Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (25%) 32.83K to 24.72K | |
| 13-Nov-23 2:49 PM View: | Venezia Rocco Chief Accounting Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 10,782 | $19.00 | $204,858.00 | (100%) 10.78K to 0 | |
| 13-Nov-23 2:44 PM View: | Santini Gino Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (26%) 31.76K to 23.64K | |
| 13-Nov-23 2:51 PM View: | Akkaraju Srinivas Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 640,688 | $19.00 | $12,173,100.00 | (100%) 640.69K to 0 | |
| 13-Nov-23 2:47 PM View: | Fundaro Paolo Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 35,794 | $19.00 | $680,086.00 | (100%) 35.79K to 0 | |
| 13-Nov-23 2:41 PM View: | Bradbury Daniel Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 23,548 | $19.00 | $447,412.00 | (75%) 31.36K to 7.81K | |
| 13-Nov-23 2:49 PM View: | Berrey M Michelle President, R&D and CMO | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 51,790 | $19.00 | $984,010.00 | (65%) 80.14K to 28.35K | |
| 13-Nov-23 2:43 PM View: | Gottesdiener Keith Michael Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 24,719 | $19.00 | $469,661.00 | (100%) 24.72K to 0 | |
| 13-Nov-23 2:44 PM View: | Miller-Rich Nancy Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (27%) 30.41K to 22.3K | |
| 13-Nov-23 2:40 PM View: | Pruzanski Mark Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 618,894 | $19.00 | $11,759,000.00 | (100%) 618.89K to 0 | |
| 13-Nov-23 2:49 PM View: | Venezia Rocco Chief Accounting Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 14,669 | $19.00 | $278,711.00 | (58%) 25.45K to 10.78K | |
| 13-Nov-23 2:42 PM View: | Freedberg Jared General Counsel | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 33,762 | $19.00 | $641,478.00 | (60%) 56.44K to 22.68K | |
| 13-Nov-23 2:43 PM View: | Rosa-Bjorkeson Dagmar Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 11,625 | $19.00 | $220,875.00 | (44%) 26.39K to 14.77K | |
| 13-Nov-23 2:42 PM View: | Freedberg Jared General Counsel | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 22,681 | $19.00 | $430,939.00 | (100%) 22.68K to 0 | |
| 13-Nov-23 2:51 PM View: | Akkaraju Srinivas Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (1%) 686.69K to 678.58K | |
| 13-Nov-23 2:44 PM View: | Santini Gino Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 23,645 | $19.00 | $449,255.00 | (100%) 23.64K to 0 | |
| 13-Nov-23 2:40 PM View: | Saik Andrew EVP & Chief Financial Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 45,244 | $19.00 | $859,636.00 | (66%) 68.27K to 23.02K | |
| 13-Nov-23 2:40 PM View: | Durso Jerome Benedict CEO Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 102,825 | $19.00 | $1,953,680.00 | (66%) 154.64K to 51.81K | |
| 13-Nov-23 2:46 PM View: | Luca Benatti Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (24%) 33.6K to 25.49K | |
| 13-Nov-23 2:41 PM View: | Bradbury Daniel Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 7,812 | $19.00 | $148,428.00 | (100%) 7.81K to 0 | |
| 13-Nov-23 2:49 PM View: | Berrey M Michelle President, R&D and CMO | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 28,349 | $19.00 | $538,631.00 | (100%) 28.35K to 0 | |
| 13-Nov-23 2:45 PM View: | Sblendorio Glenn Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 8,111 | $19.00 | $154,109.00 | (26%) 31.56K to 23.45K | |
| 13-Nov-23 2:40 PM View: | Saik Andrew EVP & Chief Financial Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 23,021 | $19.00 | $437,399.00 | (100%) 23.02K to 0 | |
| 13-Nov-23 2:42 PM View: | Ford David A Chief Human Resources Officer | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 15,038 | $19.00 | $285,722.00 | (100%) 15.04K to 0 | |
| 13-Nov-23 2:44 PM View: | Miller-Rich Nancy Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 22,304 | $19.00 | $423,776.00 | (100%) 22.3K to 0 | |
| 13-Nov-23 2:43 PM View: | Rosa-Bjorkeson Dagmar Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 14,766 | $19.00 | $280,554.00 | (100%) 14.77K to 0 | |
| 13-Nov-23 2:51 PM View: | Akkaraju Srinivas Director | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 37,887 | $19.00 | $719,853.00 | (6%) 678.58K to 640.69K | |
| 03-Nov-23 4:00 PM View: | Freedberg Jared General Counsel | Intercept Pharmaceuticals, ... (ICPT) | 01-Nov-23 | Payment of Exercise | 771 | $18.96 | $14,618.20 | (1%) 57.21K to 56.44K | |
| 25-Sep-23 4:01 PM View: | Saik Andrew EVP & Chief Financial Officer | Intercept Pharmaceuticals, ... (ICPT) | 21-Sep-23 | Payment of Exercise | 908 | $10.80 | $9,806.40 | (1%) 69.17K to 68.27K | |
| 18-Sep-23 4:01 PM View: | Berrey M Michelle President, R&D & CMO | Intercept Pharmaceuticals, ... (ICPT) | 14-Sep-23 | Payment of Exercise | 1,246 | $11.57 | $14,416.20 | (2%) 81.39K to 80.14K | |
| 03-Aug-23 4:01 PM View: | Freedberg Jared General Counsel | Intercept Pharmaceuticals, ... (ICPT) | 01-Aug-23 | Payment of Exercise | 771 | $10.50 | $8,095.50 | (1%) 57.98K to 57.21K | |
| 23-Jun-23 4:04 PM View: | Saik Andrew EVP & Chief Financial Officer | Intercept Pharmaceuticals, ... (ICPT) | 21-Jun-23 | Payment of Exercise | 908 | $11.74 | $10,659.90 | (1%) 70.08K to 69.17K | |
| 16-Jun-23 4:01 PM View: | Berrey M Michelle President, R&D & CMO | Intercept Pharmaceuticals, ... (ICPT) | 14-Jun-23 | Payment of Exercise | 1,246 | $12.04 | $15,001.80 | (2%) 82.63K to 81.39K | |
| 25-May-23 8:38 PM View: | Miller-Rich Nancy Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 36% 22.3K to 30.41K | |
| 25-May-23 8:39 PM View: | Rosa-Bjorkeson Dagmar Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 44% 18.28K to 26.39K | |
| 25-May-23 8:37 PM View: | Akkaraju Srinivas Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 1% 678.58K to 686.69K | |
| 25-May-23 8:40 PM View: | Luca Benatti Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 32% 25.49K to 33.6K | |
| 25-May-23 8:40 PM View: | Sblendorio Glenn Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 35% 23.45K to 31.56K | |
| 25-May-23 8:39 PM View: | Fundaro Paolo Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 23% 35.79K to 43.91K | |
| 25-May-23 8:37 PM View: | Bradbury Daniel Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 26% 31.36K to 39.47K | |
| 25-May-23 8:40 PM View: | Gottesdiener Keith Michael Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 33% 24.72K to 32.83K | |
| 25-May-23 8:39 PM View: | Santini Gino Director | Intercept Pharmaceuticals, ... (ICPT) | 24-May-23 | Grant | 8,111 | -- | -- | 34% 23.64K to 31.76K |
